Pages that link to "Q35867443"
Jump to navigation
Jump to search
The following pages link to Differential Use of CCR5 by HIV-1 Clinical Isolates Resistant to Small-Molecule CCR5 Antagonists (Q35867443):
Displaying 4 items.
- CCR5 susceptibility to ligand-mediated down-modulation differs between human T lymphocytes and myeloid cells. (Q36028163) (← links)
- Vicriviroc Resistance Decay and Relative Replicative Fitness in HIV-1 Clinical Isolates under Sequential Drug Selection Pressures (Q36086642) (← links)
- A common mechanism of clinical HIV-1 resistance to the CCR5 antagonist maraviroc despite divergent resistance levels and lack of common gp120 resistance mutations (Q36827946) (← links)
- The magnitude of HIV-1 resistance to the CCR5 antagonist maraviroc may impart a differential alteration in HIV-1 tropism for macrophages and T-cell subsets (Q39163578) (← links)